A major advance in cancer study is emerging with the use of nanobodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in several kinds of tumors, causing uncontrolled body https://bookmarksfocus.com/story7721268/vhh-fragments-reactivate-the-p53-protein-the-promising-approach-for-malignant-management